{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:13:43Z","timestamp":1788783223285,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100015829","name":"Ministerstwo Zdrowia","doi-asserted-by":"publisher","award":["SUBZ.C280.26.041"],"award-info":[{"award-number":["SUBZ.C280.26.041"]}],"id":[{"id":"10.13039\/501100015829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-026-06527-4","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:04:54Z","timestamp":1782212694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Copy number variants in BRCA1 and BRCA2 genes in Polish patients with breast and ovarian cancer"],"prefix":"10.1007","volume":"152","author":[{"given":"Anna","family":"Doraczynska-Kowalik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafal","family":"Matkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmara","family":"Michalowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Chrusciel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola","family":"Semeniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Blomka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Lawicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Czykalko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola","family":"Abrahamowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Pietron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Janus-Szymanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ireneusz","family":"Pawlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Maciejczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Szelachowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Laczmanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"7","key":"6527_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/S10038-023-01140-6","volume":"68","author":"T Akin Duman","year":"2023","unstructured":"Akin Duman T, Ozturk FN (2023) Frequency and distribution of BRCA1\/BRCA2 large genomic rearrangements in Turkish population with breast cancer. J Hum Genet 68(7):485\u2013490. https:\/\/doi.org\/10.1038\/S10038-023-01140-6","journal-title":"J Hum Genet"},{"issue":"13","key":"6527_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21134650","volume":"21","author":"A Bozsik","year":"2020","unstructured":"Bozsik A, P\u00f3cza T, Papp J, Vaszk\u00f3 T, Butz H, Pat\u00f3cs A et al (2020) Complex characterization of germline large genomic rearrangements of the BRCA1 and BRCA2 genes in high-risk breast cancer patients\u2014novel variants from a large national center. Int J Mol Sci 21(13):1\u201317. https:\/\/doi.org\/10.3390\/ijms21134650","journal-title":"Int J Mol Sci"},{"key":"6527_CR3","unstructured":"ClinGen ENIGMA BRCA1 and BRCA2 VARIANT Curation Expert Panel. (2024). ClinGen ENIGMA BRCA1 and BRCA2 Expert panel specifications to the ACMG\/AMP variant interpretation guidelines for BRCA1 Version 1.2.0. ClinGen Criteria Specification Registry, CSpec ID: GN092. Accessed [14\/05\/2026]"},{"key":"6527_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cca.2018.02.012","volume":"480","author":"P Concolino","year":"2018","unstructured":"Concolino P, Rizza R, Mignone F, Costella A, Guarino D, Carboni I et al (2018) A comprehensive BRCA1\/2 NGS pipeline for an immediate copy number variation (CNV) detection in breast and ovarian cancer molecular diagnosis. Clin Chim Acta 480:173\u2013179. https:\/\/doi.org\/10.1016\/j.cca.2018.02.012","journal-title":"Clin Chim Acta"},{"issue":"22","key":"6527_CR5","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","volume":"382","author":"J de Bono","year":"2020","unstructured":"de Bono J, Mateo J, Fizazi K, Saad F, Shore N, Sandhu S et al (2020) Olaparib for metastatic castration-resistant prostate cancer. N Engl J Med 382(22):2091\u20132102. https:\/\/doi.org\/10.1056\/NEJMoa1911440","journal-title":"N Engl J Med"},{"issue":"8","key":"6527_CR6","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1373\/clinchem.2006.070110","volume":"52","author":"M De La Hoya","year":"2006","unstructured":"De La Hoya M, Guti\u00e9rrez-Enr\u00edquez S, Velasco E, Osorio A, Sanchez De Abajo A, Vega A et al (2006) Genomic rearrangements at the BRCA1 locus in Spanish families with breast\/ovarian cancer. Clin Chem 52(8):1480\u20131485. https:\/\/doi.org\/10.1373\/clinchem.2006.070110","journal-title":"Clin Chem"},{"key":"6527_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.941375","author":"A Doraczynska-Kowalik","year":"2022","unstructured":"Doraczynska-Kowalik A, Michalowska D, Matkowski RA, Czykalko E, Blomka D, Semeniuk M et al (2022) Detection of BRCA1\/2 pathogenic variants in patients with breast and\/or ovarian cancer and their families. Front Genetics. https:\/\/doi.org\/10.3389\/fgene.2022.941375","journal-title":"Front Genetics"},{"issue":"7","key":"6527_CR8","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/humu.20723","volume":"29","author":"S Engert","year":"2008","unstructured":"Engert S, Wappenschmidt B, Betz B, Kast K, Kutsche M, Hellebrand H et al (2008) MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases. Hum Mutat 29(7):948\u2013958. https:\/\/doi.org\/10.1002\/humu.20723","journal-title":"Hum Mutat"},{"issue":"44","key":"6527_CR9","doi-asserted-by":"publisher","first-page":"6841","DOI":"10.1038\/sj.onc.1205685","volume":"21","author":"S Gad","year":"2002","unstructured":"Gad S, Caux-Moncoutier V, Pag\u00e8s-Berhouet S, Gauthier-Villars M, Coupier I et al (2002) Significant contribution of large BRCA1 gene rearrangements in French families. Oncogene 21(44):6841\u20136847. https:\/\/doi.org\/10.1038\/sj.onc.1205685","journal-title":"Oncogene"},{"key":"6527_CR10","doi-asserted-by":"crossref","unstructured":"Germani A, Libi F, Maggi S, Stanzani G, Lombardi A, Pellegrini P et al. (2018) Rapid detection of copy number variations and point mutations in BRCA1\/2 genes using ion semiconductor sequencing pipeline. Oncotarget. www.oncotarget.com","DOI":"10.18632\/oncotarget.26000"},{"issue":"2","key":"6527_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10549-008-0088-0","volume":"115","author":"TVO Hansen","year":"2009","unstructured":"Hansen TVO, J\u00f8nson L, Albrechtsen A, Andersen MK, Ejlertsen B, Nielsen FC (2009) Large BRCA1 and BRCA2 genomic rearrangements in Danish families. Breast Cancer Res Treat 115(2):315\u2013323. https:\/\/doi.org\/10.1007\/s10549-008-0088-0","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"6527_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/humu.9291","volume":"24","author":"C Hartmann","year":"2004","unstructured":"Hartmann C, John AL, Klaes R, Hofmann W, Bielen R, Koehler R et al (2004) Large BRCA1 gene deletions in German high-risk families. Hum Mutat 24(6):534. https:\/\/doi.org\/10.1002\/humu.9291","journal-title":"Hum Mutat"},{"issue":"1","key":"6527_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13053-017-0085-6","volume":"16","author":"C Heramb","year":"2018","unstructured":"Heramb C, Wangensteen T, Grindedal EM, Ariansen SL, Lothe S, Heimdal KR et al (2018) BRCA1 and BRCA2 mutation spectrum - an update on mutation distribution in a large cancer genetics clinic in Norway. Hered Cancer Clin Pract 16(1):3. https:\/\/doi.org\/10.1186\/s13053-017-0085-6","journal-title":"Hered Cancer Clin Pract"},{"issue":"7","key":"6527_CR14","first-page":"1449","volume":"63","author":"FBL Hogervorst","year":"2003","unstructured":"Hogervorst FBL, Nederlof PM, Gille JJP, McElgunn CJ, Grippeling M, Pruntel R et al (2003) Large genomic deletions and duplications in BRCA1. Cancer Res 63(7):1449\u20131453","journal-title":"Cancer Res"},{"key":"6527_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031205","author":"A Kasuga","year":"2022","unstructured":"Kasuga A, Okamoto T, Udagawa S, Mori C, Mie T, Furukawa T et al (2022) Molecular features and clinical management of hereditary pancreatic cancer syndromes. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23031205","journal-title":"Int J Mol Sci"},{"key":"6527_CR16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO","author":"HL Kindler","year":"2022","unstructured":"Kindler HL, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ et al (2022) Overall survival results from the POLO trial. J Clinic Oncol. https:\/\/doi.org\/10.1200\/JCO","journal-title":"J Clinic Oncol"},{"issue":"23","key":"6527_CR17","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom, et al (2017) Risks of breast and ovarian cancer for BRCA1\/2 carriers. JAMA 317(23):2402\u20132416. https:\/\/doi.org\/10.1001\/jama.2017.7112","journal-title":"JAMA"},{"issue":"8","key":"6527_CR18","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1001\/jamaoncol.2018.0644","volume":"4","author":"AW Kurian","year":"2018","unstructured":"Kurian AW, Ward KC, Hamilton AS, Deapen DM, Abrahamse P, Bondarenko I et al (2018) Uptake and outcomes of germline sequencing after breast cancer. JAMA Oncol 4(8):1066\u20131072. https:\/\/doi.org\/10.1001\/jamaoncol.2018.0644","journal-title":"JAMA Oncol"},{"issue":"9","key":"6527_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.cancergen.2015.05.031","volume":"208","author":"A Kwong","year":"2015","unstructured":"Kwong A, Chen J, Shin VY, Ho JCW, Law FBF, Au CH et al (2015) Importance of long-range rearrangement analysis of BRCA1\/2. Cancer Genet 208(9):448\u2013454. https:\/\/doi.org\/10.1016\/j.cancergen.2015.05.031","journal-title":"Cancer Genet"},{"key":"6527_CR20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41436","volume":"22","author":"H LaDuca","year":"2020","unstructured":"LaDuca H, Polley EC, Yussuf A, Hoang L, Gutierrez S, Hart SN et al (2020) Clinical guide to hereditary cancer panel testing. Genet Med 22:407\u2013415. https:\/\/doi.org\/10.1038\/s41436","journal-title":"Genet Med"},{"key":"6527_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/TACG.S245021","volume":"14","author":"L McAlarnen","year":"2021","unstructured":"McAlarnen L, Stearns K, Uyar D (2021) Challenges of genomic testing for hereditary breast and ovarian cancers. Appl Clin Genet 14:1\u20139. https:\/\/doi.org\/10.2147\/TACG.S245021","journal-title":"Appl Clin Genet"},{"issue":"5","key":"6527_CR22","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41431-023-01507-5","volume":"32","author":"T McDevitt","year":"2024","unstructured":"McDevitt T, Durkie M, Arnold N, Burghel GJ, Butler S, Claes KBM et al (2024) EMQN best practice guidelines for genetic testing in HBOC. Eur J Hum Genet 32(5):479\u2013488. https:\/\/doi.org\/10.1038\/s41431-023-01507-5","journal-title":"Eur J Hum Genet"},{"key":"6527_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174332","author":"MCS Menezes","year":"2022","unstructured":"Menezes MCS, Raheem F, Mina L, Ernst B, Batalini F (2022) PARP inhibitors for breast cancer: germline BRCA1\/2 and beyond. Cancers. https:\/\/doi.org\/10.3390\/cancers14174332","journal-title":"Cancers"},{"issue":"1","key":"6527_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10549-008-9978-4","volume":"114","author":"A Peixoto","year":"2009","unstructured":"Peixoto A, Santos C, Rocha P, Pinheiro M, Pr\u00edncipe S, Pereira D et al (2009) BRCA2 c.156-157insAlu rearrangement in Portugal. Breast Cancer Res Treatment 114(1):31\u201338. https:\/\/doi.org\/10.1007\/s10549-008-9978-4","journal-title":"Breast Cancer Res Treatment"},{"issue":"3","key":"6527_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/NG1197-341","volume":"17","author":"A Petrij-Bosch","year":"1997","unstructured":"Petrij-Bosch A, Peelen T, Van Vliet M, Van Eijk R, Olmer R, Dr\u00fcsedau M et al (1997) BRCA1 genomic deletions as founder mutations. Nat Genet 17(3):341\u2013345. https:\/\/doi.org\/10.1038\/NG1197-341","journal-title":"Nat Genet"},{"issue":"5","key":"6527_CR26","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1056\/NEJMoa1603144","volume":"375","author":"CC Pritchard","year":"2016","unstructured":"Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H et al (2016) Inherited DNA-repair gene mutations in metastatic prostate cancer. N Engl J Med 375(5):443\u2013453. https:\/\/doi.org\/10.1056\/NEJMoa1603144","journal-title":"N Engl J Med"},{"issue":"5","key":"6527_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) ACMG\/AMP variant interpretation guidelines. Genet Med 17(5):405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"issue":"12","key":"6527_CR28","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1007\/s11033-013-2775-0","volume":"40","author":"H Rudnicka","year":"2013","unstructured":"Rudnicka H, Debniak T, Cybulski C, Huzarski T, Gronwald J, Lubinski J et al (2013) Large BRCA1\/2 rearrangements in Polish families. Mol Biol Rep 40(12):6619\u20136623. https:\/\/doi.org\/10.1007\/s11033-013-2775-0","journal-title":"Mol Biol Rep"},{"issue":"6","key":"6527_CR29","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.jmoldx.2017.07.003","volume":"19","author":"AY Schmidt","year":"2017","unstructured":"Schmidt AY, Hansen TvO, Ahlborn LB, J\u00f8nson L, Yde CW, Nielsen FC (2017) NGS-based detection of germline CNVs in BRCA1\/2. J Mol Diagn 19(6):809\u2013816. https:\/\/doi.org\/10.1016\/j.jmoldx.2017.07.003","journal-title":"J Mol Diagn"},{"key":"6527_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-645","author":"MW Seong","year":"2014","unstructured":"Seong MW, Cho SI, Kim KH, Chung IY, Kang E, Lee JW et al (2014) Prevalence of BRCA1\/2 LGRs in familial breast cancer. BMC Cancer. https:\/\/doi.org\/10.1186\/1471-2407-14-645","journal-title":"BMC Cancer"},{"issue":"4","key":"6527_CR31","doi-asserted-by":"publisher","first-page":"e256215","DOI":"10.1001\/jamanetworkopen.2025.6215","volume":"8","author":"J Skorniak","year":"2025","unstructured":"Skorniak J, Rabalski L, Szynglarewicz B, Dolega-Kozierowski B, Kasprzak P, Zietek M et al (2025) Breast cancer stage among Ukrainian refugees in Poland. JAMA Netw Open 8(4):e256215. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.6215","journal-title":"JAMA Netw Open"},{"issue":"2","key":"6527_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/S10549-010-0817-Z","volume":"125","author":"MD Sluiter","year":"2011","unstructured":"Sluiter MD, Van Rensburg EJ (2011) Large genomic rearrangements of BRCA1 and BRCA2: review. Breast Cancer Res Treat 125(2):325\u2013349. https:\/\/doi.org\/10.1007\/S10549-010-0817-Z","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"6527_CR33","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","volume":"164","author":"EM Stoffel","year":"2023","unstructured":"Stoffel EM, Brand RE, Goggins M (2023) Pancreatic cancer: changing epidemiology and new approaches. Gastroenterology 164(5):752\u2013765. https:\/\/doi.org\/10.1053\/j.gastro.2023.02.012","journal-title":"Gastroenterology"},{"key":"6527_CR34","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1200\/JCO.20","volume":"38","author":"WP Tew","year":"2020","unstructured":"Tew WP, Lacchetti C, Ellis A, Maxian K, Banerjee S, Bookman M et al (2020) PARP inhibitors in ovarian cancer: ASCO guideline. J Clin Oncol 38:3468\u20133493. https:\/\/doi.org\/10.1200\/JCO.20","journal-title":"J Clin Oncol"},{"issue":"2","key":"6527_CR35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10549-010-0745-y","volume":"124","author":"I Ticha","year":"2010","unstructured":"Ticha I, Kleibl Z, Stribrna J, Kotlas J, Zimovjanova M, Mateju M et al (2010) Screening for genomic rearrangements in Czech patients. Breast Cancer Res Treat 124(2):337\u2013347. https:\/\/doi.org\/10.1007\/s10549-010-0745-y","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"6527_CR36","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.annonc.2021.11.013","volume":"33","author":"I Vergote","year":"2022","unstructured":"Vergote I, Gonz\u00e1lez-Mart\u00edn A, Ray-Coquard I, Harter P, Colombo N, Pujol P et al (2022) European consensus on BRCA\/HRD testing in ovarian cancer. Ann Oncol 33(3):276\u2013287. https:\/\/doi.org\/10.1016\/j.annonc.2021.11.013","journal-title":"Ann Oncol"},{"issue":"44","key":"6527_CR37","doi-asserted-by":"publisher","first-page":"18032","DOI":"10.1073\/pnas.1115052108","volume":"108","author":"T Walsh","year":"2011","unstructured":"Walsh T, Casadei S, Lee MK, Pennil CC, Nord AS, Thornton AM et al (2011) Mutations in 12 genes for inherited ovarian carcinoma. Proc Natl Acad Sci U S A 108(44):18032\u201318037. https:\/\/doi.org\/10.1073\/pnas.1115052108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6527_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/2045-3701-2-6","author":"B Wang","year":"2012","unstructured":"Wang B (2012) BRCA1 tumor suppressor network. Cell Biosci. https:\/\/doi.org\/10.1186\/2045-3701-2-6","journal-title":"Cell Biosci"},{"key":"6527_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13530-6","author":"Y Wang","year":"2019","unstructured":"Wang Y, Bernhardy AJ, Nacson J, Krais JJ, Tan YF, Nicolas E et al (2019) BRCA1 intronic Alu elements drive rearrangements. Nature Commun. https:\/\/doi.org\/10.1038\/s41467-019-13530-6","journal-title":"Nature Commun"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-026-06527-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06527-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06527-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:03:27Z","timestamp":1788782607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-026-06527-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["6527"],"URL":"https:\/\/doi.org\/10.1007\/s00432-026-06527-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9336936\/v1","asserted-by":"object"}]},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"6 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is an observational study. The Wroclaw Medical University Ethics Committee has confirmed that no ethical approval is required (No. 233\/2025).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent for genetic diagnostics was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"175"}}